ECHA management board elects new deputy chairman

Martin Lynch takes the role

You may also like

Ingredients

Safe and accurate flow measurement for pharmaceutical production

Oval Gear (OG) meters from Titan Enterprises, fitted with a Namur sensor, provide consistent, accurate measurement across a wide range of liquids, from low-viscosity solvents to more viscous pharmaceutical ingredients
Manufacturing

NorthStar and QSA Global sign multi-year partnership to secure actinium-225 supply chain

NorthStar Medical Radioisotopes and QSA Global have announced a new strategic services agreement to support commercial-scale production of actinium-225 through a closed-loop radium-226 target supply and recycling programme for targeted alpha therapies
Ingredients

Pioneering AAV approach unlocks cause of rheumatoid arthritis pain

Karolinska Institute researchers use AAV products to uncover neural mechanisms behind rheumatoid arthritis pain
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Pharma supply chains face record drug shortages as geopolitical, cyber and quality risks converge

A new Moody's report identifies four compounding risk factors driving pharmaceutical supply chain instability and warns that siloed risk management is leaving the sector dangerously exposed
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Rice-ing to the occasion: how plant-based excipients are gaining ground in pharmaceutical manufacturing

As clean-label expectations migrate from health foods into pharmaceutical supply chains, natural ingredient supplier RIBUS says that rice-based excipients are becoming a credible alternative to synthetic standards
Ingredients

The impact of Brexit on raw materials testing for the pharmaceutical industry (2026 update)

Since the UK departed from the EU, the pharmaceutical regulatory landscape has undergone significant and lasting change; whereas early uncertainty has largely subsided, the system has evolved into a stable but more complex dual framework
Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Subscribe now